Literature DB >> 11296954

Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus.

H Ogasawara1, T Naito, H Kaneko, T Hishikawa, I Sekigawa, H Hashimoto, Y Kaneko, N Yamamoto, N Maruyama, N Yamamoto.   

Abstract

OBJECTIVE: Human endogenous retrovirus (HERV) has emerged as a possible causative agent of systemic lupus erythematosus (SLE). To investigate the role of HERV in the etiology of SLE, we performed quantitative analyses of messenger RNA (mRNA) of the HERV clone 4-1 in patients with SLE.
METHODS: Reverse transcriptase (RT)-polymerase chain reaction (PCR) and real-time quantitative PCR (RQ-PCR; TaqMan methodology) were used in this experiment.
RESULTS: The quantities of mRNA of the HERV clone 4-1 gag region in patients with SLE were significantly higher than in healthy controls, and the amounts of such mRNA in the patients were decreased by steroid treatment.
CONCLUSION: These phenomena may be related to the production of viral components derived from HERV clone 4-1 and contribute to the pathogenesis of SLE; studies using a larger number of patients are required to confirm these points.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11296954

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  The evolution, distribution and diversity of endogenous retroviruses.

Authors:  Robert Gifford; Michael Tristem
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

2.  DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.

Authors:  Tinhinane Fali; Christelle Le Dantec; Yosra Thabet; Sandrine Jousse; Catherine Hanrotel; Pierre Youinou; Wesley H Brooks; Andras Perl; Yves Renaudineau
Journal:  Autoimmunity       Date:  2013-10-14       Impact factor: 2.815

3.  Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies.

Authors:  Piotr C Piotrowski; Sergiusz Duriagin; Paweł P Jagodzinski
Journal:  Clin Rheumatol       Date:  2005-07-13       Impact factor: 2.980

4.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 5.  HERVs in neuropathogenesis.

Authors:  Tove Christensen
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-27       Impact factor: 4.147

6.  Transposable element dysregulation in systemic lupus erythematosus and regulation by histone conformation and Hsp90.

Authors:  Maurer Kelly; Shi Lihua; Zhang Zhe; Song Li; Paucar Yoselin; Petri Michelle; E Sullivan Kathleen
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

7.  Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus.

Authors:  Toshio Naito; Hitoshi Ogasawara; Hiroshi Kaneko; Takashi Hishikawa; Iwao Sekigawa; Hiroshi Hashimoto; Naoki Maruyama
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

8.  Expression of Human Endogenous Retroviruses in Systemic Lupus Erythematosus: Multiomic Integration With Gene Expression.

Authors:  Nathaniel Stearrett; Tyson Dawson; Ali Rahnavard; Prathyusha Bachali; Matthew L Bendall; Chen Zeng; Roberto Caricchio; Marcos Pérez-Losada; Amrie C Grammer; Peter E Lipsky; Keith A Crandall
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

Review 9.  Human endogenous retrovirus group E and its involvement in diseases.

Authors:  Christelle Le Dantec; Sophie Vallet; Wesley H Brooks; Yves Renaudineau
Journal:  Viruses       Date:  2015-03-16       Impact factor: 5.048

10.  B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.

Authors:  Tomasz Brudek; Tove Christensen; Lars Aagaard; Thor Petersen; Hans J Hansen; Anné Møller-Larsen
Journal:  Retrovirology       Date:  2009-11-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.